CD19-Targeted CAR-T Cells in Refractory Systemic Lupus Erythematosus: Safety, Efficacy, and Mechanistic Insights from the First Five Patients

Müller F, Völkl S, Mougiakakos D, Böltz S, Aigner M, Gary R, Kretschmann S, Kharboutli S, Kleyer A, Simon D, Rösler W, Habenicht KM, Winkler T, Krönke G, Schett G, Mackensen A (2022)


Publication Type: Conference contribution

Publication year: 2022

Journal

Publisher: AMER SOC HEMATOLOGY

City/Town: WASHINGTON

Pages Range: 4562-4563

Conference Proceedings Title: BLOOD

Event location: New Orleans, LA US

DOI: 10.1182/blood-2022-165077

Authors with CRIS profile

How to cite

APA:

Müller, F., Völkl, S., Mougiakakos, D., Böltz, S., Aigner, M., Gary, R.,... Mackensen, A. (2022). CD19-Targeted CAR-T Cells in Refractory Systemic Lupus Erythematosus: Safety, Efficacy, and Mechanistic Insights from the First Five Patients. In BLOOD (pp. 4562-4563). New Orleans, LA, US: WASHINGTON: AMER SOC HEMATOLOGY.

MLA:

Müller, Fabian, et al. "CD19-Targeted CAR-T Cells in Refractory Systemic Lupus Erythematosus: Safety, Efficacy, and Mechanistic Insights from the First Five Patients." Proceedings of the 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA WASHINGTON: AMER SOC HEMATOLOGY, 2022. 4562-4563.

BibTeX: Download